日(ri)前，国(guo)家(jia)发展(zhan)改革委公(gong)布了新(xin)序列国(guo)家(jia)工(gong)程研(yan)究(jiu)中(zhong)心入选(xuan)名单。根据部署，2021年(nian)国(guo)家(jia)发展(zhan)改革委先后分两批对(dui)现(xian)有349家(jia)国(guo)家(jia)工(gong)程研(yan)究(jiu)中(zhong)心和(he)国(guo)家(jia)工(gong)程实验室进行优化整合，经过严格评审，最终191家(jia)获(huo)准纳入新(xin)序列。国(guo)药(yao)集团新(xin)型疫苗(miao)国(guo)家(jia)工(gong)程研(yan)究(jiu)中(zhong)心和(he)医药(yao)先进制(zhi)造国(guo)家(jia)工(gong)程研(yan)究(jiu)中(zhong)心成功入选(xuan)。
新型(xing)(xing)疫(yi)苗(miao)国(guo)家(jia)工程研(yan)(yan)究(jiu)中(zhong)(zhong)心依托国(guo)药(yao)中(zhong)(zhong)生(sheng)生(sheng)物技术研(yan)(yan)究(jiu)院有(you)限公司组(zu)建，是全国(guo)唯一的(de)国(guo)家(jia)级新型(xing)(xing)疫(yi)苗(miao)研(yan)(yan)发(fa)和产(chan)业化(hua)的(de)基地及服(fu)务平台(tai)，主(zhu)要从事新型(xing)(xing)疫(yi)苗(miao)、重组(zu)蛋(dan)白(bai)(bai)、多(duo)肽药(yao)物、核酸药(yao)物、诊断试(shi)剂等生(sheng)物医药(yao)的(de)研(yan)(yan)究(jiu)开发(fa)，近年(nian)来成功研(yan)(yan)发(fa)上市国(guo)家(jia)一类(lei)新药(yao)肠道病毒(du)71型(xing)(xing)灭活疫(yi)苗(miao)，获(huo)得重组(zu)新型(xing)(xing)冠状病毒(du)疫(yi)苗(miao)、重组(zu)诺如(ru)病毒(du)双价疫(yi)苗(miao)、注射用NVS451融合(he)蛋(dan)白(bai)(bai)等多(duo)个国(guo)家(jia)一类(lei)新药(yao)的(de)临床批件。
医(yi)药(yao)(yao)先进制(zhi)(zhi)(zhi)造国(guo)(guo)(guo)家(jia)工(gong)(gong)程研(yan)(yan)究(jiu)(jiu)中(zhong)心(xin)(xin)由(you)原药(yao)(yao)物制(zhi)(zhi)(zhi)剂国(guo)(guo)(guo)家(jia)工(gong)(gong)程研(yan)(yan)究(jiu)(jiu)中(zhong)心(xin)(xin)（1995年成立）优(you)化(hua)(hua)(hua)整合而成,上海现代(dai)药(yao)(yao)物制(zhi)(zhi)(zhi)剂工(gong)(gong)程研(yan)(yan)究(jiu)(jiu)中(zhong)心(xin)(xin)有限公(gong)司为(wei)牵头建设单位，隶属于(yu)中(zhong)国(guo)(guo)(guo)医(yi)药(yao)(yao)工(gong)(gong)业(ye)研(yan)(yan)究(jiu)(jiu)总院。该中(zhong)心(xin)(xin)自成立以来已(yi)建成十余(yu)类(lei)国(guo)(guo)(guo)内领先的新型(xing)制(zhi)(zhi)(zhi)剂开发(fa)与(yu)工(gong)(gong)程化(hua)(hua)(hua)研(yan)(yan)究(jiu)(jiu)技术(shu)平台，拥(yong)有国(guo)(guo)(guo)家(jia)药(yao)(yao)品监督(du)管(guan)理局（NMPA）药(yao)(yao)品包装材料科研(yan)(yan)检验(yan)中(zhong)心(xin)(xin)和(he)NMPA药(yao)(yao)包材与(yu)药(yao)(yao)物相容性研(yan)(yan)究(jiu)(jiu)重点(dian)实验(yan)室，开发(fa)了40余(yu)种国(guo)(guo)(guo)内独家(jia)或首(shou)家(jia)新型(xing)制(zhi)(zhi)(zhi)剂产(chan)品，在新型(xing)制(zhi)(zhi)(zhi)剂工(gong)(gong)程化(hua)(hua)(hua)和(he)产(chan)业(ye)化(hua)(hua)(hua)研(yan)(yan)究(jiu)(jiu)领域积累了独特的技术(shu)优(you)势。
纳入新(xin)序列管理的国(guo)家工程研究中(zhong)(zhong)心(xin)将按国(guo)家发(fa)改(gai)委要求(qiu)坚持以国(guo)家和行业(ye)(ye)战(zhan)略需求(qiu)为出发(fa)点，聚(ju)焦解决经济社会(hui)发(fa)展中(zhong)(zhong)的“卡脖子”技术问题(ti)，打造成为提升产(chan)(chan)业(ye)(ye)创(chuang)新(xin)效率、推动创(chuang)新(xin)链产(chan)(chan)业(ye)(ye)链深度融合的国(guo)家战(zhan)略科技力量。
